Coiled-coil lipopeptides mimicking the prehairpin intermediate of glycoprotein gp41.

[1]  H. Mantsch,et al.  Apocytochrome c interaction with phospholipid membranes studied by Fourier-transform infrared spectroscopy. , 1991, Biochemistry.

[2]  D. Marsh,et al.  Investigation of secondary and tertiary structural changes of cytochrome c in complexes with anionic lipids using amide hydrogen exchange measurements: an FTIR study. , 1993, Biophysical journal.

[3]  Tom Alber,et al.  Crystal structure of an isoleucine-zipper trimer , 1994, Nature.

[4]  T. Heimburg,et al.  Specific recognition of coiled coils by infrared spectroscopy: analysis of the three structural domains of type III intermediate filament proteins. , 1996, Biochemistry.

[5]  K. Tan,et al.  Atomic structure of a thermostable subdomain of HIV-1 gp41. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P S Kim,et al.  Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Eric Hunter,et al.  Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry , 1998, Nature Medicine.

[8]  P. S. Kim,et al.  HIV Entry and Its Inhibition , 1998, Cell.

[9]  T. Heimburg,et al.  FTIR-Spectroscopy of multistranded coiled coil proteins. , 1999, Biochemistry.

[10]  R. Doms,et al.  HIV-1 Membrane Fusion , 2000, The Journal of cell biology.

[11]  P S Kim,et al.  Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.

[12]  Cheng-Wei Wu,et al.  The LLSGIV stretch of the N-terminal region of HIV-1 gp41 is critical for binding to a model peptide, T20. , 2003, Protein engineering.

[13]  N. Meanwell,et al.  Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Shibo Jiang,et al.  Different from the HIV Fusion Inhibitor C34, the Anti-HIV Drug Fuzeon (T-20) Inhibits HIV-1 Entry by Targeting Multiple Sites in gp41 and gp120* , 2005, Journal of Biological Chemistry.

[15]  S. Kent,et al.  In Situ Neutralization in Boc-chemistry Solid Phase Peptide Synthesis , 2007, International Journal of Peptide Research and Therapeutics.

[16]  R. Schooley,et al.  Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion , 2006, Proceedings of the National Academy of Sciences.

[17]  E. Prenner,et al.  Optimization of the hydrochloric acid concentration used for trifluoroacetate removal from synthetic peptides , 2007, Journal of peptide science : an official publication of the European Peptide Society.

[18]  Andreas Janshoff,et al.  Phase transition of individually addressable microstructured membranes visualized by imaging ellipsometry. , 2007, The journal of physical chemistry. B.

[19]  T. Matthews,et al.  Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus , 2007, Proceedings of the National Academy of Sciences.

[20]  Shibo Jiang,et al.  HIV gp41 C-terminal Heptad Repeat Contains Multifunctional Domains , 2007, Journal of Biological Chemistry.

[21]  B. Treutlein,et al.  In situ synthesis of lipopeptides as versatile receptors for the specific binding of nanoparticles and liposomes to solid-supported membranes. , 2008, Small.